Synapse - Advanced Practice Providers

Results (161)

Cystic renal cell carcinoma: A report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging

Journal Article

Kashan, M.; Ghanaat, M.; Hötker, A. M.; Duzgol, C.; Sanchez, A.; DiNatale, R. G.; Blum, K. A.; Becerra, M. F.; Manley, B. J.; Casuscelli, J.; more...
Journal of Urology (2018)

Fulltext@MSK | Save

Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster

Journal Article

Landgren, O.; Zeig-Owens, R.; Giricz, O.; Goldfarb, D.; Murata, K.; Thoren, K.; Ramanathan, L.; Hultcrantz, M.; Dogan, A.; Nwankwo, G.; more...
JAMA Oncology (2018)

Fulltext@MSK | Save

Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

Journal Article

Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
European Journal of Cancer (2018)

Fulltext@MSK | Save

Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM

Meeting Abstract

Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
Blood (2017)

Fulltext@MSK | Save

Feasibility, tolerability, and patient-reported outcomes with pharmacokinetic (PK)-directed dosing of Evomela (propylene glycol free melphalan) for multiple myeloma and AL amyloidosis patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S. J.; Hoover, E.; Chung, D. J.; more...
Blood (2017)

Fulltext@MSK | Save

A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
Blood (2017)

Fulltext@MSK | Save

In vitro, in vivo, and parallel phase I evidence support the safety and activity of duvelisib, a PI3K-δ,γ inhibitor, in combination with romidepsin or bortezomib in relapsed/refractory T-cell lymphoma

Meeting Abstract

Moskowitz, A. J.; Koch, R.; Mehta-Shah, N.; Myskowski, P.; Kheterpal, M.; Dogan, A.; Davey, T.; Galasso, N.; Evan, M.; Shah, M.; more...
Blood (2017)

Fulltext@MSK | Save

Identifying oncogenic pathways in renal cell carcinoma with unclassified histology (uRCC): A validation study of 59 patients

Meeting Abstract

Chen, Y. B.; Ghanaat, M.; Hakimi, A.; Al-Ahmadie, H.; Fine, S. W.; Gopalan, A.; Sirintrapun, S. J.; Jayakumaran, G.; Arcila, M. E.; Lee, C. H.; more...
Modern Pathology (2017)

Fulltext@MSK | Save

Identifying oncogenic pathways in renal cell carcinoma with unclassified histology (uRCC): A validation study of 59 patients

Meeting Abstract

Chen, Y. B.; Ghanaat, M.; Hakimi, A.; Al-Ahmadie, H.; Fine, S. W.; Gopalan, A.; Sirintrapun, S. J.; Jayakumaran, G.; Arcila, M. E.; Lee, C. H.; more...
Laboratory Investigation (2017)

Fulltext@MSK | Save